Role of Integrated PET/CT Fusion in Lung Carcinoma

Abstract

Positron emission tomography has emerged as an important diagnostic tool in the management of lung cancers. PET is sensitive
in the detection of lung cancer, but FDG (2-deoxy-2-18uro-D-glucose) is not tumor specic and may accumulate in a variety of
non-malignant conditions occasionally giving false negative result. The addition of CT to PET improves specicity foremost, but
also sensitivity in tumor imaging. Thus, PET/CT fusion images are a more accurate test than either of its individual components
and are probably also better than side-by-side viewing of images from both modalities. PET/CT fusion images are useful in
differentiating between malignant and benign disease, brosis and recurrence, staging and in changing patient management to a
more appropriate therapy. With analysis and discussion, it appears that PET/ CT fusion images have the potential to dramatically
improve our ability to manage the patients with lung cancer and is contributing to our understanding of cancer cell biology and in
the development of new therapies.
Keywords: Positron emission tomography (PET), CAT scan (CT), Lung carcinoma.
Joshi, S., Pant, I., Khan, F., Shukla, A., & Gokula, K. (2008). Role of Integrated PET/CT Fusion in Lung Carcinoma. International Journal of Health Sciences, 2(1). Retrieved from https://pub.qu.edu.sa/index.php/journal/article/view/76
Copyright and license info is not available
Author biographies is not available.

Most read articles by the same author(s)